Complementary synaptic distribution of enzymes responsible for synthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in the human hippocampus.
Ludányi
A
A
Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, H-1083, Szigony utca 43, Hungary.
Hu
S S-J
SS
Yamazaki
M
M
Tanimura
A
A
Piomelli
D
D
Watanabe
M
M
Kano
M
M
Sakimura
K
K
Maglóczky
Z
Z
Mackie
K
K
Freund
T F
TF
Katona
I
I
D000818:Animals; D001095:Arachidonic Acids / Q000378:metabolism*; D063385:Cannabinoid Receptor Modulators / Q000378:metabolism*; D049229:Dendritic Spines / Q000201:enzymology; D063388:Endocannabinoids; D005989:Glycerides / Q000378:metabolism*; D006624:Hippocampus / Q000378:metabolism* / Q000648:ultrastructure; D006801:Humans; D007150:Immunohistochemistry; D008071:Lipoprotein Lipase / Q000235:genetics / Q000378:metabolism*; D051379:Mice; D018345:Mice, Knockout; D009928:Organ Specificity; D017729:Presynaptic Terminals / Q000201:enzymology; D015398:Signal Transduction; D013045:Species Specificity; D013569:Synapses / Q000201:enzymology*
D001095:Arachidonic Acids; D063385:Cannabinoid Receptor Modulators; D063388:Endocannabinoids; D005989:Glycerides; C094503:glyceryl 2-arachidonate; C480280:DAGLA protein, human; D008071:Lipoprotein Lipase